$MRNA

Moderna Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$104.19 β–Ό-0.067%

Extented Hours

VOLUME

3,296,647

DAY RANGE

99.3301 - 104.8163

52 WEEK

95.02 - 217.25

Join Discuss about MRNA with like-minded investors

SC
@scottzman #droscrew
recently

wth is up with MRNA

127 Replies 8 πŸ‘ 8 πŸ”₯

DA
@danbrey #ivtrades
recently

I didn't follow the stop out rule on $MRNA which is a gamble. Now, I looking for higher profit probability combo trades.. I still have some high risk options which need to be washed out.

113 Replies 10 πŸ‘ 14 πŸ”₯

profile
@JohnnyFive #ivtrades
recently

MRNA stopped out last Thursday

111 Replies 6 πŸ‘ 7 πŸ”₯

profile
@thegiz18 #ivtrades
recently

$MRNA looked bad for a while, but much better position now, It also had a lot more time to work with 6wks to expiry at entry. I didn't take it though.

131 Replies 11 πŸ‘ 11 πŸ”₯

DA
@danbrey #ivtrades
recently

At least I made 80 on the MRNA PUT.

64 Replies 9 πŸ‘ 6 πŸ”₯

profile
@thegiz18 #ivtrades
recently

$MRNA turned around a bit today and took out yesterdays high, still a ways to the stop, though not a great sign

92 Replies 13 πŸ‘ 8 πŸ”₯

TR
@trademaster #TradeHouses
recently

By Bansari Mayur Kamdar and Johann M Cherian (Reuters) - Wall Street's main indexes slipped on Wednesday as investors awaited minutes of the Federal Reserve's June meeting for clues on the central bank's monetary policy path, while Sino-U.S. tensions and weak economic data from Beijing dented sentiment. Investors are focused on the Fed minutes, expected to be released around 2 p.m. ET, as they resume trading after the July 4 Independence Day holiday. Bets for a 25-basis-point rate hike in July stood at 83%, while traders have priced in a 32% chance the U.S. central bank would deliver another hike by October, according to Refinitiv data. [IRPR] "There is going to be a little bit of dissension among the ranks and the overall tone will be let's see how this plays out," said Robert Pavlik, senior portfolio manager at Dakota Wealth. "Stocks have accounted for another 25 basis point rate hike when the Fed meets later this month, but a lot of people are divided on whether or not there's going to be another rate hike (after July)." Nine of the 11 major S&P 500 sectors fell in early trading with material shares leading declines, down 1.7%, while financials lost 0.9%. Traders also await U.S. factory orders data, due at 10 a.m. ET, to gauge the impact of higher rates on the economy after a survey showed on Monday manufacturing slumped in June. More economic data, including the non-farm payrolls report on Friday, is scheduled for release later this week. Chip stocks such as Nvidia (NASDAQ:NVDA) and Micron Technology (NASDAQ:MU) fell 0.7% and 1.0%, respectively, after China said it would control exports of some metals widely used in the semiconductor industry as tensions between Beijing and Washington rise over access to high-tech microchips. The Philadelphia SE Semiconductor Index lost 0.9%. Shares of Wolfspeed gained 12.8% after the company signed a 10-year silicon carbide wafer supply agreement with Renesas Electronics Corp. U.S. main indexes kicked off the third quarter with slim gains in a holiday-shortened session on Monday, led by Tesla (NASDAQ:TSLA) after the electric-vehicle company posted record second-quarter deliveries. At 9:48 a.m. ET, the Dow Jones Industrial Average was down 147.62 points, or 0.43%, at 34,270.85, the S&P 500 was down 11.10 points, or 0.25%, at 4,444.49, and the Nasdaq Composite was down 6.07 points, or 0.04%, at 13,810.71. China's June services activity expanded at the slowest pace in five months, raising concerns about global economic recovery, a private-sector survey showed. Among other movers, Netflix (NASDAQ:NFLX) gained 1.8% as Goldman Sachs (NYSE:GS) raised its rating and price target. United Parcel Service (NYSE:UPS) slid 2.1% after the Teamsters Union and the postal service operator accused each other of walking away from negotiations. Moderna (NASDAQ:MRNA) rose 4.4% after the drugmaker signed an agreement to work towards opportunities to research, develop and manufacture mRNA medicines in China. Declining issues outnumbered advancers by a 3.73-to-1 ratio on the NYSE and a 2.24-to-1 ratio on the Nasdaq. The S&P index recorded 6 new 52-week highs and one new low, while the Nasdaq recorded 23 new highs and 21 new lows.

46 Replies 13 πŸ‘ 14 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

take note of this today...$MRNA, $MRK, $JNJ, $LLY has some news than we dont know because are active today

110 Replies 7 πŸ‘ 15 πŸ”₯

TR
@trademaster #TradeHouses
recently

By Liz Moyer Investing.com -- U.S. stocks were falling on Friday after comments from Federal Reserve officials renewed fears about interest rates. At 9:48 ET (14:48 GMT), the Dow Jones Industrial Average was down 124 points or 0.4%, while the S&P 500 was down 0.8% and the NASDAQ Composite was down 1.2%. Hotter-than-expected producer prices on Thursday prompted fears that the Fed would keep its monetary restrictive for the rest of the year. And St. Louis Fed President James Bullard said he wouldn't rule out supporting a half-percentage point rate increase at the March meeting. Many market watchers have been betting on a quarter of a percentage point increase. Bullard said Thursday he supported the idea of a half-point hike in February to bring the benchmark rate above 5% as soon as possible. Cleveland Fed President Loretta Mester also said she saw a strong case for a bigger increase. Richmond Fed President Thomas Barkin and Fed Gov. Michelle Bowman are scheduled to speak today. Stocks have gyrated this week after the economic data pointing to inflation as well as a tight labor market. Shares of Moderna (NASDAQ:MRNA) fell 6.1% after its experimental mRNA flu vaccine wasn't as effective as an approved vaccine against influenza B. DraftKings (NASDAQ:DKNG) shares jumped 17.1% after the gambling company reported a smaller-than-expected loss in the quarter and raised its outlook for 2023, benefiting as more states legalize sports betting. Deere & Company (NYSE:DE) shares rose 5% after it raised guidance as farmers continue to buy new agriculture equipment. Oil fell. Crude Oil WTI Futures was down 3.9% to $75.44 a barrel, while Brent Oil Futures was down 3.5% to $82.15 a barrel. Gold Futures was down 1% to $1840.

138 Replies 12 πŸ‘ 6 πŸ”₯

profile
@Navneet #droscrew
recently

$mrna 215 calls 2/17 10k volume but OI is same

57 Replies 12 πŸ‘ 7 πŸ”₯

profile
@dros #droscrew
recently

Peyote > @Pal said: $MRNA Thought meeting was yesterday @navneet Where do you get your news? Serious question for a Friday afternoon

53 Replies 8 πŸ‘ 7 πŸ”₯

profile
@Pal #droscrew
recently

$MRNA Thought meeting was yesterday @navneet Where do you get your news? Serious question for a Friday afternoon

48 Replies 9 πŸ‘ 9 πŸ”₯

profile
@Navneet #droscrew
recently

$mrna 215 calls flow is coming

110 Replies 14 πŸ‘ 15 πŸ”₯

profile
@Navneet #droscrew
recently

$mrna 215 call 0.45 weekly

114 Replies 11 πŸ‘ 11 πŸ”₯

profile
@Housty #droscrew
recently

if you took the MRNA vaccine and you want to know the truth about it https://podcasts.apple.com/ca/podcast/quoth-the-raven-301-dr-peter-a-mccullough/id1348446973?i=1000590481935

136 Replies 12 πŸ‘ 12 πŸ”₯

profile
@Navneet #droscrew
recently

whats going on with $mrna

73 Replies 11 πŸ‘ 9 πŸ”₯

profile
@Navneet #droscrew
recently

$mrna 200 calls jan 2023

40 Replies 13 πŸ‘ 8 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

$MRNA - Bullish option flow detected in Moderna (179.72 +3.81) with 14,325 calls trading (2x expected) and implied vol increasing over 3 points to 62.29%. . The Put/Call Ratio is 0.30. Earnings are expected on 02/22. The Dec 2nd 185 & 190 Calls are active

64 Replies 10 πŸ‘ 14 πŸ”₯

profile
@matteochinaglia #decarolis
recently

MODERNA (MRNA) Come possiamo vedere il titolo in questione proviene da una fase laterale molto lunga partita da febbraio 2022, io personalmente ho segnato due livelli importanti per me - livello nΒ°1 a 190,38$ - livello nΒ°2 a 118,29$ Il titolo Γ¨ da monitorare

99 Replies 15 πŸ‘ 6 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

$MRNA - Bearish flow noted in Moderna (128.38 -5.71) with 8,428 puts trading, or 1.7x expected. The Put/Call Ratio is 1.55, while ATM IV is up over 1 point on the day. Earnings are expected on 11/02. The OCT 21st 129 .00 & 130.00 Puts are active.

128 Replies 12 πŸ‘ 15 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

137.7s needs to top out > @soheil.n said: $MRNA - another mover

49 Replies 7 πŸ‘ 8 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$mrna $apdn $pegy going big

72 Replies 10 πŸ‘ 12 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$MRNA - another mover

111 Replies 15 πŸ‘ 15 πŸ”₯

profile
@Navneet #droscrew
recently

wtf with $mrna

127 Replies 7 πŸ‘ 11 πŸ”₯

profile
@dros #droscrew
recently

$CVNA Sep23 50 C $JBLU Sep23 8 C $SBUX Sep 94 C $MRNA Sep 140 C $AAPL Oct07 160 C $SWBI Oct 12.5 C $GH Nov 65 C $SNOW Sep 200 C

143 Replies 14 πŸ‘ 12 πŸ”₯

profile
@dros #droscrew
recently

RECAP 9/14 Unusual Calls: $CVNA Sep23 50 C $JBLU Sep23 8 C $SBUX Sep 94 C $MRNA Sep 140 C $AAPL Oct07 160 C $SWBI Oct 12.5 C $GH Nov 65 C $SNOW Sep 200 C

64 Replies 13 πŸ‘ 7 πŸ”₯

profile
@Benlax #droscrew
recently

Covered a little more mrna and rblx +21% and +19%

67 Replies 15 πŸ‘ 8 πŸ”₯

profile
@Benlax #droscrew
recently

Covered more dkng +12% and mrna +7.5% > @Benlax said: Shorted some MRNA

55 Replies 12 πŸ‘ 11 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$veru $siga $amc $nvax $mrna $li daily's then $petz $ormp $rytm $th $goss $goev

138 Replies 10 πŸ‘ 7 πŸ”₯

profile
@singletary #StockTraders.NET
recently

alright charts setting up now focusing in $th $veru $siga $mrna

40 Replies 6 πŸ‘ 12 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$amc $li $mrna $nvax my daily's. others $th $ormp $veru

73 Replies 13 πŸ‘ 6 πŸ”₯

profile
@singletary #StockTraders.NET
recently

I'm not even sized $ormp but instantly down -5k from missing the cover. I'd have to be stupid on $mrna $amc and miss my cover and ignore the chart 3x that to be the same amount

105 Replies 9 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$mrna $nvax $amc $nio other plays so much more profitable

64 Replies 10 πŸ‘ 10 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$mrna 176 is of interest on the way back down, not up

107 Replies 7 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$mrna $180 $170 clear channel. will participate everyday til we get the $10 red day . it doesn't have to happen now and I'll let it keep going, but will watch for it and participate until we have it

87 Replies 6 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

well actually not big cus I wired my account to small lol damnit not much bp $mrna

134 Replies 15 πŸ‘ 14 πŸ”₯

profile
@singletary #StockTraders.NET
recently

going big on $mrna if stay sub vwap

42 Replies 15 πŸ‘ 8 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$bhat nice macro clear out. added $th to watch. will focus $mrna

75 Replies 13 πŸ‘ 11 πŸ”₯

profile
@singletary #StockTraders.NET
recently

πŸ‘€ $mrna $nvax $ormp $plrx $kspn $veru $amc

116 Replies 7 πŸ‘ 10 πŸ”₯

ST
@stevengo #StockTraders.NET
recently

Insider selling hitting the tape. > @singletary said: speaking of double top. look at $mrna vs yesterday. so clean

54 Replies 8 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

speaking of double top. look at $mrna vs yesterday. so clean

103 Replies 11 πŸ‘ 9 πŸ”₯

profile
@Benlax #droscrew
recently

Shorted some MRNA

137 Replies 8 πŸ‘ 8 πŸ”₯

profile
@dros #droscrew
recently

that doesn't seem so far-fetched > @lucullus said: latest out of Sweden is that the MRNA vaccine can alter the DNA of cells .... so you could be continously generating the spike protein

96 Replies 7 πŸ‘ 8 πŸ”₯

profile
@Housty #droscrew
recently

latest out of Sweden is that the MRNA vaccine can alter the DNA of cells .... so you could be continously generating the spike protein

47 Replies 14 πŸ‘ 14 πŸ”₯

profile
@Navneet #droscrew
recently

still loss in $mrna

146 Replies 14 πŸ‘ 12 πŸ”₯

profile
@Navneet #droscrew
recently

loss in $mrna 😞

62 Replies 9 πŸ‘ 12 πŸ”₯

Key Metrics

Market Cap

39.23 B

Beta

0

Avg. Volume

3.68 M

Shares Outstanding

380.59 M

Yield

0%

Public Float

0

Next Earnings Date

2023-11-02

Next Dividend Date

Company Information

moderna is pioneering messenger rna therapeuticsβ„’, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. this breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions. moderna has developed a broad intellectual property estate including more than 200 patent applications with more than 10,000 claims ranging from novel nucleotide chemistries to specific drug compositions. the company plans to develop and commercialize its innovative mrna drugsβ€”initially for rare diseases and oncologyβ€”while partnering drug candidates in other therapeutics areas in order to rapidly deliver this innovation to patients. based in cambridge, massachusetts, moderna is privately held and was founded in 2010 by flagship venturelabs in association with leading scientists from boston children’s hospital a

CEO: Stephane Bancel

Website:

HQ: 200 Technology Sq Cambridge, 02139-3578 Massachusetts

Related News